Eurofins-Cerep SA (EPA:ALECR)
France · Delayed Price · Currency is EUR 17,800
0.00 (0.00%)
Dec 29, 2025, 4:43 PM CET
Eurofins-Cerep Market Cap
Eurofins-Cerep has a market cap or net worth of €89.78 million as of January 12, 2026. Its market cap has decreased by -9.18% in one year.
Market Cap
89.78M
Enterprise Value
76.20M
Revenue
38.86M
Ranking
n/a
PE Ratio
14.57
Stock Price
€17,800.00
Market Cap Chart
Since January 5, 2015, Eurofins-Cerep's market cap has decreased from 1.18B to 89.78M, a decrease of -92.38%. That is a compound annual growth rate of -20.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 89.78M | - |
| Dec 31, 2025 | 89.78M | -9.18% |
| Dec 31, 2024 | 98.86M | -21.60% |
| Dec 29, 2023 | 126.10M | 45.35% |
| Dec 23, 2021 | 86.76M | 32.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 125.76B |
| Sanofi | 100.86B |
| Sartorius Stedim Biotech | 21.47B |
| bioMérieux | 13.42B |
| Eurofins Scientific SE | 12.17B |
| Ipsen | 10.40B |
| ABIVAX Société Anonyme | 7.72B |
| Virbac | 3.03B |